Global Acute Ischemic Stroke Drugs Market Report 2024

Acute Ischemic Stroke Drugs Global Market Report 2023 – By Type (Tablet, Capsule, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hospitals, Diagnostic Centers, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Acute Ischemic Stroke Drugs Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Acute ischemic stroke drugs refer to treatment medications for a medical emergency that occurs when blood flow to the brain is interrupted, typically due to a blood clot. These drugs aim to restore blood flow to the affected part of the brain and minimize brain damage.

The main forms of acute ischemic stroke drugs are tablets, capsules, and other types. A tablet refers to a solid unit-dose form of medication that contains the proper excipients. It is made up of a mixture of excipients and active ingredients that are often in powder form and are compressed or pressed into a solid dosage. These are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and primarily used in hospitals, diagnostic centers, and other applications.

The global acute ischemic stroke drugs market is segmented -

1) By Type: Tablet, Capsule, Other Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Hospitals, Diagnostic Centers, Other Applications

The global acute ischemic stroke drugs market size is expected to grow from $12.43 billion in 2022 to $13.01 billion in 2023 at a compound annual growth rate (CAGR) of 4.69%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global acute ischemic stroke drugs market size is expected to reach $15.88 billion in 2027 at a CAGR of 5.11%.

The rise in the prevalence of chronic diseases is anticipated to propel the growth of the acute ischemic stroke drug market in the coming years. Chronic diseases, also known as non-communicable diseases, refer to conditions that endure for a year or longer and necessitate continuing medical care, restrict everyday activities, or both. The primary causes of death and disability are chronic illnesses like heart disease, cancer, and diabetes. Acute ischemic stroke drugs are primarily used in chronic diseases to reduce the chances of clot formation and strokes and restore blood flow to the brain. For instance, in September 2022, according to the reports shared by the World Health Organization (WHO), a Switzerland-based health agency, due to chronic diseases, it is estimated 41 million people die each year, which is equivalent to 74% of all deaths globally, and 17 million individuals die before the age of 70 from chronic diseases. By 2025, an estimated 164 million Americans, or nearly 49% of the population, would be living with chronic illnesses. Therefore, the rise in the prevalence of chronic diseases is driving the growth of the acute ischemic stroke drug market.

Major players in the acute ischemic stroke drugs market are F. Hoffmann-La Roche AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo Company Limited, AstraZeneca plc, ZZ Biotech, NoNO Inc., Biogen Inc, Athersys Inc., Bayer AG, Sanofi S.A., Pfizer Inc., DiaMedica Therapeutics, Lumosa Therapeutics Co. Ltd., Janssen Pharmaceuticals, and Acticor Biotech.

Strategic clinical development is a key trend gaining popularity in the acute ischemic stroke drugs market. Major companies operating in the acute ischemic stroke drugs market are focusing on clinical developments to sustain their position in the market. For instance, in May 2021, Biogen Inc., a US-based biotechnology company, purchased the investigational drug TMS-007 for acute ischemic stroke. TMS-007 has the potential to be a next-generation thrombolytic with improved benefits and risk profile. The TMS-007 Phase 2a study also demonstrated positive impacts on blood vessel reopening and patient functional recovery with no incidence of symptomatic intracranial haemorrhage.

The growing demand for diagnostic centers is expected to propel the growth of the acute ischemic stroke drugs market in the coming years. A diagnostic center is a location that evaluates any health conditions and offers treatment as necessary. The timely and accurate diagnosis is crucial in the effective treatment of acute ischemic stroke, and diagnostic centers play a key role in diagnosing and managing the condition. For instance, in April 2022, according to the reports shared by GOV.UK, a UK-based government digital service provider, 73 diagnostic centers operated and performed 30,000 more tests per week in 2022. And by 2025, there could be 160 community diagnostic centers. Therefore, the growing demand for diagnostic centers is driving the growth of the acute ischemic stroke drugs market.

North America was the largest region in the acute ischemic stroke drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global acute ischemic stroke drugs market report during the forecast period. The regions covered in the global acute ischemic stroke drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute ischemic stroke drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The acute ischemic stroke drugs market consists of sales of alteplase drugs, antiplatelet drugs, clopidogrel drugs, aspirin drugs, and anticoagulant drugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The acute ischemic stroke drugs market research report is one of a series of new reports from The Business Research Company that provides acute ischemic stroke drugs market statistics, including acute ischemic stroke drugs industry global market size, regional shares, competitors with a acute ischemic stroke drugs market share, detailed acute ischemic stroke drugs market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke drugs industry. This acute ischemic stroke drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Acute Ischemic Stroke Drugs Market Characteristics

    3. Acute Ischemic Stroke Drugs Market Trends And Strategies

    4. Acute Ischemic Stroke Drugs Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Acute Ischemic Stroke Drugs Market

    4.2. Ukraine-Russia War Impact On Acute Ischemic Stroke Drugs Market

    4.3. Impact Of High Inflation On Acute Ischemic Stroke Drugs Market

    5. Acute Ischemic Stroke Drugs Market Size And Growth

    5.1. Global Acute Ischemic Stroke Drugs Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Acute Ischemic Stroke Drugs Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Acute Ischemic Stroke Drugs Market Segmentation

    6.1. Global Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Tablet

    Capsule

    Other Types

    6.2. Global Acute Ischemic Stroke Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    6.3. Global Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Diagnostic Centers

    Other Applications

    7. Acute Ischemic Stroke Drugs Market Regional And Country Analysis

    7.1. Global Acute Ischemic Stroke Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Acute Ischemic Stroke Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Acute Ischemic Stroke Drugs Market

    8.1. Asia-Pacific Acute Ischemic Stroke Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Acute Ischemic Stroke Drugs Market

    9.1. China Acute Ischemic Stroke Drugs Market Overview

    9.2. China Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Acute Ischemic Stroke Drugs Market

    10.1. India Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Acute Ischemic Stroke Drugs Market

    11.1. Japan Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Acute Ischemic Stroke Drugs Market

    12.1. Australia Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Acute Ischemic Stroke Drugs Market

    13.1. Indonesia Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Acute Ischemic Stroke Drugs Market

    14.1. South Korea Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Acute Ischemic Stroke Drugs Market

    15.1. Western Europe Acute Ischemic Stroke Drugs Market Overview

    15.2. Western Europe Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Acute Ischemic Stroke Drugs Market

    16.1. UK Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Acute Ischemic Stroke Drugs Market

    17.1. Germany Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Acute Ischemic Stroke Drugs Market

    18.4. France Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Acute Ischemic Stroke Drugs Market

    19.1. Eastern Europe Acute Ischemic Stroke Drugs Market Overview

    19.2. Eastern Europe Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Acute Ischemic Stroke Drugs Market

    20.1. Russia Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Acute Ischemic Stroke Drugs Market

    21.1. North America Acute Ischemic Stroke Drugs Market Overview

    21.2. North America Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Acute Ischemic Stroke Drugs Market

    22.1. USA Acute Ischemic Stroke Drugs Market Overview

    22.2. USA Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Acute Ischemic Stroke Drugs Market

    23.1. South America Acute Ischemic Stroke Drugs Market Overview

    23.2. South America Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Acute Ischemic Stroke Drugs Market

    24.1. Brazil Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Acute Ischemic Stroke Drugs Market

    25.1. Middle East Acute Ischemic Stroke Drugs Market Overview

    25.2. Middle East Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Acute Ischemic Stroke Drugs Market

    26.1. Africa Acute Ischemic Stroke Drugs Market Overview

    26.2. Africa Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Acute Ischemic Stroke Drugs Market Competitive Landscape And Company Profiles

    27.1. Acute Ischemic Stroke Drugs Market Competitive Landscape

    27.2. Acute Ischemic Stroke Drugs Market Company Profiles

    27.2.1. F. Hoffmann-La Roche AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Boehringer Ingelheim

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bristol-Myers Squibb

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Daiichi Sankyo Company Limited

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AstraZeneca plc

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Acute Ischemic Stroke Drugs Market

    29. Acute Ischemic Stroke Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Acute Ischemic Stroke Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Acute Ischemic Stroke Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Acute Ischemic Stroke Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: F. Hoffmann-La Roche AG Financial Performance
  • Table 47: Boehringer Ingelheim Financial Performance
  • Table 48: Bristol-Myers Squibb Financial Performance
  • Table 49: Daiichi Sankyo Company Limited Financial Performance
  • Table 50: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Acute Ischemic Stroke Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Acute Ischemic Stroke Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Acute Ischemic Stroke Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Acute Ischemic Stroke Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Acute Ischemic Stroke Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: F. Hoffmann-La Roche AG Financial Performance
  • Figure 47: Boehringer Ingelheim Financial Performance
  • Figure 48: Bristol-Myers Squibb Financial Performance
  • Figure 49: Daiichi Sankyo Company Limited Financial Performance
  • Figure 50: AstraZeneca plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report